Circulating Tumor DNA Collection From Patients With High Grade Gliomas
Condition(s):High Grade GliomaLast Updated:December 26, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):High Grade GliomaLast Updated:December 26, 2023Recruiting
Condition(s):Glioma, MalignantLast Updated:January 29, 2024Recruiting
Condition(s):Solid Tumors, Glioblastoma, Recurrent Malignant GliomasLast Updated:September 22, 2023Active, not recruiting
Condition(s):High-grade GliomaLast Updated:August 21, 2023Not yet recruiting
Condition(s):Recurrent High Grade GliomasLast Updated:May 8, 2013Completed
Condition(s):Malignant Glioma; Life ExperiencesLast Updated:April 20, 2022Completed
Condition(s):Malignant GliomaLast Updated:October 23, 2023Completed
Condition(s):Recurrent High Grade GliomaLast Updated:February 23, 2024Recruiting
Condition(s):EphA2 Positive Malignant Glioma; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn
Condition(s):High Grade Glioma; Glioma; Glioma, Malignant; Neoplasms, Neuroepithelial; Neuroectodermal Tumors; Photosensitizing Agents; Neoplasm Malignant; Brain Neoplasms, Adult, Malignant; Central Nervous System Neoplasms; Brain Tumor; Tumour, ResidualLast Updated:May 9, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.